본문 바로가기
  • Home

An overview of Acne Vulgaris (Busoor Labaniya)

  • CELLMED
  • Abbr : CellMed
  • 2022, 12(2), pp.9-9
  • DOI : 10.5667/CellMed.2022.009
  • Publisher : Cellmed Orthocellular Medicine and Pharmaceutical Association
  • Research Area : Medicine and Pharmacy > General Medicine
  • Received : March 24, 2022
  • Accepted : May 20, 2022
  • Published : May 31, 2022

Mehnaz 1 Yasmeen Shamsi 2 Md. Wasi Akhtar 1 Sahar Zaidi 1 Sujata Mohanty 3 Sayeed Ahmad 1

1Jamia Hamdard
2Department of Moalajat, SUMER, Jamia Hamdard
3AIIMS

Accredited

ABSTRACT

Acne vulgaris is a common dermatological condition affecting the pilosebaceous units and having a multifactorial etiology. In Unani terminology, acne vulgaris is referred as Busoor Labaniya, characterized by white lesions on the face, nose, and cheeks; on squeezing, release cheesy material. In conventional medicine, mild cases are best addressed with topical regimens, but more severe cases require systemic medications. Retinoids (retinoic acid, adapalene, isotretinoin, tazarotene), benzoyl peroxide, clindamycin, erythromycin, and azelaic acid are a few examples of topical medications, whereas systemic drugs include antibiotics (Doxycycline, minocycline, erythromycin, azithromycin). In the Unani System of Medicine, numerous single and compound drugs have been used to treat Busoor Labaniya. These drugs are considered harmless and do not have any major side effects. In Unani system of medicine, acne vulgaris is effectively managed with natural medicines as well as therapeutic regimens with minimal side effects even after long-term usage. Acne vulgaris is usually treated with systemic blood purifiers along with topical Unani drugs. Hence, clinical studies with proper scientific parameters are needed to be conducted to establish and validate their efficacy in the prevention and control of acne vulgaris.

Citation status

* References for papers published after 2022 are currently being built.